Cinctive Capital Management LP Makes New Investment in Healthpeak Properties, Inc. (NYSE:DOC)

Cinctive Capital Management LP bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 636,443 shares of the real estate investment trust’s stock, valued at approximately $14,555,000. Healthpeak Properties makes up approximately 0.8% of Cinctive Capital Management LP’s investment portfolio, making the stock its 29th largest position. Cinctive Capital Management LP owned approximately 0.09% of Healthpeak Properties as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. HM Payson & Co. purchased a new stake in Healthpeak Properties in the 3rd quarter worth approximately $25,000. S.A. Mason LLC acquired a new stake in shares of Healthpeak Properties in the third quarter worth $26,000. Rise Advisors LLC bought a new stake in Healthpeak Properties during the third quarter valued at about $29,000. Fortitude Family Office LLC bought a new stake in Healthpeak Properties during the 3rd quarter valued at approximately $32,000. Finally, Barrett & Company Inc. acquired a new stake in shares of Healthpeak Properties in the third quarter worth $33,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Trading Down 1.1 %

NYSE DOC opened at $21.99 on Monday. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The firm has a market cap of $15.38 billion, a P/E ratio of 46.79, a P/E/G ratio of 2.45 and a beta of 1.13. The stock’s 50-day moving average is $22.18 and its 200-day moving average is $21.24. Healthpeak Properties, Inc. has a one year low of $16.01 and a one year high of $23.26.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.32). The firm had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The business’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.45 EPS. Sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.30 per share. The ex-dividend date was Monday, November 4th. This represents a $1.20 annualized dividend and a yield of 5.46%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 255.32%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on DOC shares. Evercore ISI lifted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, September 16th. Wells Fargo & Company reiterated an “equal weight” rating and set a $23.00 target price (up previously from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. Citigroup boosted their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and increased their price target for the company from $20.00 to $28.00 in a research note on Monday, October 21st. Finally, Royal Bank of Canada raised their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Healthpeak Properties currently has an average rating of “Moderate Buy” and a consensus target price of $22.86.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.